Industrial Automation in Drug Discovery

Промышленная автоматизация в поиске лекарственных препаратов
Amit Kumar Tyagi, Shabnam Kumari, V. Hemamalini, P. Vasuki
2024-04-22

Industry 5.0artificial intelligence (AI)high-throughput screeningindustrial automationrobotics
This chapter explores the transformative impact of industrial automation on drug discovery, specifically within the context of the emerging paradigm of Industry 5.0. The convergence of advanced technologies, including robotics, artificial intelligence, and the internet of things (IoT), is reshaping the landscape of pharmaceutical manufacturing, leading to the development of smart manufacturing processes tailored for the intricacies of drug discovery. Industry 5.0, characterized by the integration of cyber-physical systems with human-centric approaches, provides a framework for the evolution of pharmaceutical manufacturing towards increased automation and intelligence. In drug discovery, industrial automation streamlines processes such as compound synthesis, high-throughput screening, and quality control, resulting in enhanced efficiency, precision, and reproducibility. Robotic systems, equipped with AI-driven algorithms, play a pivotal role in automating labor-intensive tasks, reducing human error, and expediting the drug development pipeline.
1
AI-driven robotic systems automate labor-intensive tasks, reduce human error, and accelerate the drug development pipeline.
2
Convergence of robotics, artificial intelligence, and IoT is reshaping pharmaceutical manufacturing and enabling smart manufacturing processes for drug discovery.
3
Industrial automation streamlines compound synthesis, high-throughput screening, and quality control, improving efficiency, precision, and reproducibility in drug discovery.
4
Industry 5.0 principles (cyber-physical systems with human-centric approaches) provide a framework for evolving pharmaceutical manufacturing toward greater automation and intelligence.

Industrial automation systems applied to drug discovery (including robotics, AI, and IoT-enabled smart manufacturing processes)

How industrial automation (robotics, AI, IoT, cyber-physical systems) transforms drug discovery workflows—streamlining compound synthesis, high-throughput screening, quality control, and increasing efficiency, precision, and reproducibility within an Industry 5.0 human-centric framework

Publication Details
Publication Date
2024-04-22
Journal
Publisher
ISSN
Cited by
10
Access Type
Author Information
Authors
Amit Kumar Tyagi
Shabnam Kumari
V. Hemamalini
P. Vasuki
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat
Make a presentation
100%